Use of rectal hydroxyprogesterone capronate phonophoresis for correction of endocrine disorders in patients with prostatic adenoma
Grigor'eva, V.D.; Sapozhnikov, V.V.; Ponomarev, I.T.; Bobkova, A.S.; Korobkina, E.G.
Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1984(6): 29-32
1984
ISSN/ISBN: 0042-8787 PMID: 6084361 Document Number: 240835
Document emailed within 1 workday
Related Documents
Grigor'eva, V.D.; Sapozhnikov, V.V. 1983: Effect of ultrasound on the physicochemical properties of hydroxyprogesterone capronate (an experimental study) Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 2: 33-35Barnaba, T. 1970: Description of some cases of mammary and uterine carcinoma treated with hydroxyprogesterone capronate Minerva Ginecologica 22(19): 957-963
Iunda, N.F.; Imshinetskaia, L.P.; Gorpinchenko, I.I.; Demchenko, V.N.; Fedorchenko, P.M. 1986: Status of the hypophyseal-gonadal system in sex disorders in patients with prostatic adenoma Vrachebnoe Delo 6: 75-77
Divila, F.; Presl, J.; Stroufová, A. 1977: Stimulating action of a combination of oestradiol with 17alpha-hydroxyprogesterone-capronate upon the LH elimination in women with stein-leventhal syndrome clinically diagnosed Ceskoslovenska Gynekologie 42(1): 11-14
Pasechnikov, A.P. 1976: Dignosis of functional disorders of the lower urinary tract in prostatic adenoma Klinicheskaia Khirurgiia 00(9): 51-53
Shafranov, D.V.; Mariupol'skiĭ, A.A. 2011: Vitaprost-forte in the treatment of patients with prostatic adenoma Urologiia 6: 54; 56-59
Miller, A.M.; Iaroshenko, V.P.; Soroka, P.V.; Stakhnev, E.I. 2008: Efficacy of vitaprost forte in patients with prostatic adenoma Urologiia 5: 50; 52-54
Danilov, V.V.; Vasil'chenko, A.V.; Danilova, T.I.; Besedin, S.A.; Borshchenko, S.A.; Danilov, V.V. 2010: Pharmacourodynamic non-invasive studies in patients with prostatic adenoma Urologiia 6: 16-19
Glybochko, P.V.; Anafin, T.G.; Shalekenov, S.B. 2011: Combined endoscopic treatment of patients with prostatic adenoma Urologiia 6: 81-83
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Tachev, S.; Petrov, P.; Simeonov, P. 1988: Therapeutic potentials of the preparation dibenziran in patients with prostatic adenoma Khirurgiia 41(4): 30-32
Buĭlov, V.M. 1984: X-ray television study in the excretory urography of patients with prostatic adenoma Vestnik Rentgenologii i Radiologii 1984(1): 79-82
Steinmetz, L.; Adamkiewicz, K. 1974: Urine flowmetry in patients with prostatic adenoma treated with Raveron Polski Przeglad Chirurgiczny 46(10a): 1375-1382
Maksimov, V.A.; Khodyreva, L.A.; Dudareva, A.A.; Al'bitskaia, A.I. 2011: Combined treatment of patients with prostatic adenoma and overactive bladder Urologiia 6: 46; 48-50
Champault, G.; Bonnard, A.M.; Cauquil, J.; Patel, J.C. 1984: Medical treatment of prostatic adenoma. Controlled trial: PA 109 vs placebo in 110 patients Annales d'Urologie 18(6): 407-410
Aliaev, I.G.; Gadzhieva, Z.K.; Petrovskiĭ, N.V. 2010: Overactive bladder in patients with infravesical obstruction caused by prostatic adenoma Urologiia 6: 10-15
Le Normand, L. 1999: Several difficult diagnoses of dysuria in patients with prostatic adenoma: value of urodynamic studies Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 9(1): 142-145
Vinarov, A.Z.; Aliaev, I.G.; Lokshin, K.L. 2009: Safety of continuous (more than 1 year) intake of Serenoa repens extract by patients with prostatic adenoma Urologiia 1: 84; 86-87
Horton, W.A.; Calli, L.J. 1971: Multiple endocrine adenomatosis presenting as Zollinger-Ellison syndrome, nonbeta islet cell adenoma, parathyroid adenoma, renal calculi, bronchial carcinoid, insulinoma, hepatic hamartoma, etc Birth Defects Original Article Series 7(6): 275-277
Bednyĭ, V.G. 1997: Transvesical partial electric resection of prostatic adenoma in patients with a high degree of surgical risk Likars'ka Sprava 1997(2): 49-51